Quorum Innovations rebrands QI-601 as MyGutGuardian

Quorum Innovations is renaming its flagship consumer product QI-601 as MyGutGuardian Powered by QI-601, starting immediately. The company says the new brand is meant to make the same patented microplastic-focused technology easier for consumers to understand while packaging and marketing transition.

Why it matters: - Quorum Innovations is trying to make a technical consumer product easier to recognize and shop for. - The rebrand keeps the same underlying formulation in place while giving the product a more consumer-friendly name. - The move could affect how the product is presented across retail, e-commerce, healthcare and international channels.

What happened: - Quorum Innovations announced that its flagship consumer product, QI-601, will now be marketed as MyGutGuardian™ Powered by QI-601®. - The announcement came on August 13, 2026, from Sarasota, Florida. - The company says the new name will begin appearing immediately on product packaging, marketing materials and consumer communications. - During the transition, consumers may see either QI-601 or MyGutGuardian while inventories are updated.

The details: - MyGutGuardian is the new consumer brand for the same patented technology behind QI-601. - Nicholas T. Monsul, M.D., and Eva Ann Berkes, M.D., developed the technology. - The product is described as a patented, non-drug, non-systemic biofilm postbiotic technology. - The technology is designed to bind and retain micro- and nanoplastics in the digestive tract so they can be eliminated through the body’s normal digestive process. - Quorum Innovations says the product is a once-daily supplement. - The company says more than 50 patents have been issued, with additional patents pending. - The technology has been accepted for presentation at leading scientific conferences. - The company says the technology was developed through two Direct-to-Phase II programs from the U.S. Defense Advanced Research Projects Agency. - Quorum Innovations participated in the U.S. Department of Health and Human Services’ Strategic Testing to Reduce the Impact of Microplastics initiative, known as STOMP. - The company says the technology has also received international media coverage. - More information is available through Quorum Innovations media relations.

Between the lines: - The rebrand is as much a messaging change as a product change. - Quorum Innovations is betting that a simpler name will help consumers understand the product’s purpose faster. - The company is positioning MyGutGuardian around a broader market opportunity tied to concern about micro- and nanoplastics in food, water, beverages and everyday products. - The unchanged formulation message is meant to reduce confusion during the rollout.

What's next: - MyGutGuardian will gradually replace QI-601 across consumer-facing materials as existing inventory turns over. - Quorum Innovations expects the new brand to strengthen its position in retail, e-commerce, healthcare and international markets. - Consumers should expect a transition period where both names appear on shelves and in marketing.

The bottom line: - Quorum Innovations is using a new name to make the same technology easier to sell, explain and scale.